TRAVERE THERAPEUTICS, INC. (TVTX) /
The debt of TRAVERE THERAPEUTICS, INC. over the past 10 years
Chart TRAVERE THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, TRAVERE THERAPEUTICS, INC. had liquid cash of $322.8M and total debt of $311.72M: net cash of $11.07M. It had more liquid cash than debt at 9 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2024 ($378.99M) and lowest at the end of fiscal 2016 ($44.42M).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $322.8M* | $311.72M | $11.07M |
| 2024ended Dec 31, 2024 | $370.7M* | $378.99M | -$8.29M |
| 2023ended Dec 31, 2023 | $566.85M* | $377.26M | $189.59M |
| 2022ended Dec 31, 2022 | $450.25M* | $375.55M | $74.7M |
| 2021ended Dec 31, 2021 | $552.88M* | $226.58M | $326.3M |
| 2020ended Dec 31, 2020 | $361.59M* | $215.34M | $146.25M |
| 2019ended Dec 31, 2019 | $398.52M* | $204.86M | $193.66M |
| 2018ended Dec 31, 2018 | $471.54M* | $217.55M | $253.99M |
| 2017ended Dec 31, 2017 | $300.63M* | $45.08M | $255.55M |
| 2016ended Dec 31, 2016 | $255.87M* | $44.42M | $211.45M |
Fiscal years as TRAVERE THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TRAVERE THERAPEUTICS, INC.
- The revenue of TRAVERE THERAPEUTICS, INC.
- The profitability of TRAVERE THERAPEUTICS, INC.
- The cash flow of TRAVERE THERAPEUTICS, INC.
- All of TRAVERE THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
Not investment advice. This page shows what TRAVERE THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.